Association between plasma fluorescent oxidation products and erectile dysfunction: A prospective study

DSpace/Manakin Repository

Association between plasma fluorescent oxidation products and erectile dysfunction: A prospective study

Citable link to this page

 

 
Title: Association between plasma fluorescent oxidation products and erectile dysfunction: A prospective study
Author: Yang, Shuman; Giovannucci, Edward; Bracken, Bruce; Ho, Shuk-Mei; Wu, Tianying

Note: Order does not necessarily reflect citation order of authors.

Citation: Yang, Shuman, Edward Giovannucci, Bruce Bracken, Shuk-Mei Ho, and Tianying Wu. 2015. “Association between plasma fluorescent oxidation products and erectile dysfunction: A prospective study.” BMC Urology 15 (1): 85. doi:10.1186/s12894-015-0083-9. http://dx.doi.org/10.1186/s12894-015-0083-9.
Full Text & Related Files:
Abstract: Background: Existing epidemiological studies of the association between oxidative stress and erectile dysfunction (ED) are sparse and inconclusive, which is likely due to cross-sectional design and small sample size. Therefore, we investigated the association between biomarkers of oxidative stress and ED in prospective setting among a relatively large sample size of men. Methods: We conducted the prospective study among 917 men ages between 47 and 80 years at the time of blood draw, which is a part of nested prospective case–control study of prostate cancer in the Health Professionals Follow-up Study. Plasma fluorescent oxidation products (FlOPs), a global biomarker for oxidative stress, were measured at three excitation/emission wavelengths (360/420 nm named as FlOP_360; 320/420 nm named as FlOP_320 and 400/475 nm named as FlOP_400). Results: Approximately 35 % of men developed ED during follow-up. We did not find an independent association between FlOP_360, FlOP_320, FlOP_400 and risk of ED in the multivariable adjusted model (Tertile 3 vs. tertile 1: odds ratio [OR] = 0.90, 95 % confidence interval [CI] = 0.61-1.34, Ptrend = 0.54 for FlOP_360; OR = 0.73, 95 % CI = 0.49-1.07, Ptrend = 0.27 for FlOP_320; and OR = 0.98, 95 % CI = 0.66-1.45, Ptrend = 0.72 for FlOP_400). Further analysis of the association between FlOPs and ED in the fasting samples or controls only (free of prostate cancer incidence) did not change the results appreciably. Conclusions: Plasma FlOPs were not associated with the risk of ED, suggesting oxidative stress may not be an independent risk factor for ED. Electronic supplementary material The online version of this article (doi:10.1186/s12894-015-0083-9) contains supplementary material, which is available to authorized users.
Published Version: doi:10.1186/s12894-015-0083-9
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536733/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:21459067
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters